Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis
TC-TAVR was associated with improved 30-day clinical outcomes compared with SAVR, with no significant differences in death, stroke, and hospitalization at 1-year follow-up. These findings suggest that TC-TAVR may be a valid alternative to SAVR in nontransfemoral-TAVR candidates.
Authors
- Anthony Poulin (ORCID: https://orcid.org/0000-0002-8629-0605)
- Siddhartha Mengi (ORCID: https://orcid.org/0000-0001-6825-8794)
- Frederic Beaupré (ORCID: https://orcid.org/0000-0003-0630-3144)
- Éric Dumont (ORCID: https://orcid.org/0000-0001-7513-0326)
- Pedro Luis Cepas Guillén (ORCID: https://orcid.org/0000-0001-8814-7039)
- Juan Portillo (ORCID: https://orcid.org/0000-0002-2756-7635)
- Dimitri Kalavrouziotis
- Jean Porterie (ORCID: https://orcid.org/0000-0001-7695-0844)
- Siamak Mohammadi (ORCID: https://orcid.org/0000-0001-7622-4172)
- Josep Rodés‐Cabau (ORCID: https://orcid.org/0000-0001-8237-7095)
- Marisa Avvedimento (ORCID: https://orcid.org/0000-0002-8443-7888)
- Silvia Mas‐Peiró (ORCID: https://orcid.org/0000-0002-3828-8180)
- Jean-Michel Paradis
Institutions
- Montreal Heart Institute (CA)
- Université Laval (CA)
Publication Details
- Journal
- Circulation Cardiovascular Interventions
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1161/circinterventions.124.014928
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39